SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001516551-23-000044
Filing Date
2023-08-07
Accepted
2023-08-07 16:37:17
Documents
69
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q skye-20230630.htm   iXBRL 10-Q 935481
2 EX-10.1 amendedandrestatedlease-ro.htm EX-10.1 637806
3 EX-31.1 skye-20230630xex311.htm EX-31.1 10490
4 EX-31.2 skye-20230630xex312.htm EX-31.2 11019
5 EX-32.1 skye-20230630xex321.htm EX-32.1 5071
6 EX-32.2 skye-20230630xex322.htm EX-32.2 5211
  Complete submission text file 0001516551-23-000044.txt   6649133

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT skye-20230630.xsd EX-101.SCH 57696
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT skye-20230630_cal.xml EX-101.CAL 62945
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT skye-20230630_def.xml EX-101.DEF 306932
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT skye-20230630_lab.xml EX-101.LAB 636235
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT skye-20230630_pre.xml EX-101.PRE 421114
63 EXTRACTED XBRL INSTANCE DOCUMENT skye-20230630_htm.xml XML 652998
Mailing Address 11250 EL CAMINO REAL, SUITE 100 SAN DIEGO CA 92130
Business Address 11250 EL CAMINO REAL, SUITE 100 SAN DIEGO CA 92130 (858) 410-0266
Skye Bioscience, Inc. (Filer) CIK: 0001516551 (see all company filings)

IRS No.: 450692882 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55136 | Film No.: 231148106
SIC: 2834 Pharmaceutical Preparations